T1	Spec 349 357	assessed
T2	SNP 451 482	single nucleotide polymorphisms
T3	SNP 484 487	SNP
R1	Equiv Arg1:T3 Arg2:T2	
T4	Cancer 317 344	contralateral breast cancer
T5	Association 306 316	developing
E1	Association:T5 snp_int:T2 bc:T4
R2	Speculation_marker Arg1:E1 Arg2:T1	
T6	Entity 112 117	BRCA1
T7	Entity 122 127	BRCA2
R3	SNP_coupled_gene Arg1:T2 Arg2:T7	
R4	SNP_coupled_gene Arg1:T2 Arg2:T6	
A1	Cancer_Type T4 Recurrent
T8	Cell_types_tissues_affected 317 337	contralateral breast
E2	Cell_types_tissues_affected:T8 Agent:T2
T9	Level 1008 1022	No significant
T10	Association 1023 1034	association
E3	Association:T10 bc:T11 snp_int:E4
A2	Level E3 Low
R5	Level_marker Arg1:E3 Arg2:T9	
T11	Cancer 1094 1121	contralateral breast cancer
A3	Cancer_Type T11 Recurrent
T12	Interaction 1053 1089	overall breast cancer risk SNP score
E4	Interaction:T12 Entity:T2
T18	Cell_types_tissues_affected 1094 1114	contralateral breast
E7	Cell_types_tissues_affected:T18 Agent:E4
A5	Level E7 Low
R6	Level_marker Arg1:E7 Arg2:T9	
T13	Spec 1776 1785	assessing
T14	SNP 1708 1711	SNP
R7	Equiv Arg1:T14 Arg2:T2	
T15	Cancer 1786 1813	contralateral breast cancer
A4	Cancer_Type T15 Recurrent
T16	Cell_types_tissues_affected 1786 1806	contralateral breast
E5	Cell_types_tissues_affected:T16 Agent:T14
R8	Speculation_marker Arg1:E5 Arg2:T13	
T17	Association 1814 1818	risk
E6	Association:T17 bc:T15
R9	Speculation_marker Arg1:E6 Arg2:T13	
